Article
MSX2 represses tumor stem cell phenotypes within oral squamous cell carcinomas via SOX2 degradation.
Experimental biology and medicine (Maywood, N.J.) - 1 Dec 2021
Keyimu Reziwan, Tuerdi Maimaitituxun, Zhao Zhihe
Abstract excerpt
Oral squamous cell carcinoma (OSCC) is the sixth malignancy in the world with high incidence. The MSX2 (muscle segment homeobox 2)-Sry-related high-mobility box 2 (SOX2) signaling pathway plays a significant role in maintaining cancer stem cells, which are the origin of malignancy, leading to unfavorable outcomes in several carcinomas. This study aims to elucidate the mechanisms through which the MSX2-SOX2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
